Yuya Oguro

650 total citations
15 papers, 450 citations indexed

About

Yuya Oguro is a scholar working on Molecular Biology, Oncology and Organic Chemistry. According to data from OpenAlex, Yuya Oguro has authored 15 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 6 papers in Oncology and 4 papers in Organic Chemistry. Recurrent topics in Yuya Oguro's work include Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Yuya Oguro is often cited by papers focused on Cancer therapeutics and mechanisms (4 papers), HER2/EGFR in Cancer Research (4 papers) and Angiogenesis and VEGF in Cancer (4 papers). Yuya Oguro collaborates with scholars based in Japan and United States. Yuya Oguro's co-authors include Akira Hori, Shinichi Imamura, Hiroshi Miki, Naoki Miyamoto, Hidehisa Iwata, Terufumi Takagi, Kengo Okada, Keiji Kamiyama, Zenyu Shiokawa and Hideaki Tojo and has published in prestigious journals such as Cancer Research, Journal of Medicinal Chemistry and Chemical Science.

In The Last Decade

Yuya Oguro

14 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yuya Oguro Japan 11 263 205 99 43 40 15 450
Hanumantharayappa Bharathkumar India 9 209 0.8× 150 0.7× 121 1.2× 54 1.3× 16 0.4× 14 374
Han-Li Huang Taiwan 12 277 1.1× 102 0.5× 98 1.0× 24 0.6× 20 0.5× 18 387
Tatiana McHardy United Kingdom 8 281 1.1× 148 0.7× 62 0.6× 34 0.8× 72 1.8× 11 389
Jonathan J. Hollick United Kingdom 9 374 1.4× 127 0.6× 251 2.5× 31 0.7× 10 0.3× 14 703
Scott Wolfrom United States 6 251 1.0× 128 0.6× 58 0.6× 27 0.6× 84 2.1× 7 446
Ching-Ping Chen Taiwan 8 200 0.8× 359 1.8× 66 0.7× 16 0.4× 14 0.3× 9 511
Jee Sun Yang South Korea 13 240 0.9× 153 0.7× 78 0.8× 23 0.5× 14 0.3× 17 419
Taijin Wang China 10 264 1.0× 201 1.0× 124 1.3× 26 0.6× 45 1.1× 25 447
Mei‐Jung Lai Taiwan 14 282 1.1× 162 0.8× 101 1.0× 28 0.7× 8 0.2× 26 425
David R. Goode United States 7 252 1.0× 103 0.5× 84 0.8× 13 0.3× 27 0.7× 7 374

Countries citing papers authored by Yuya Oguro

Since Specialization
Citations

This map shows the geographic impact of Yuya Oguro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yuya Oguro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yuya Oguro more than expected).

Fields of papers citing papers by Yuya Oguro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yuya Oguro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yuya Oguro. The network helps show where Yuya Oguro may publish in the future.

Co-authorship network of co-authors of Yuya Oguro

This figure shows the co-authorship network connecting the top 25 collaborators of Yuya Oguro. A scholar is included among the top collaborators of Yuya Oguro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yuya Oguro. Yuya Oguro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Oguro, Yuya, et al.. (2024). 2 H -Thiazolo[4,5- d ][1,2,3]triazole: synthesis, functionalization, and application in scaffold-hopping. Chemical Science. 15(38). 15835–15840.
2.
Ikeda, Shuhei, Hideyuki Sugiyama, Masataka Murakami, et al.. (2021). Design and Synthesis of Novel Spiro Derivatives as Potent and Reversible Monoacylglycerol Lipase (MAGL) Inhibitors: Bioisosteric Transformation from 3-Oxo-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl Moiety. Journal of Medicinal Chemistry. 64(15). 11014–11044. 26 indexed citations
3.
Kurasawa, Osamu, T. Miyazaki, Misaki Homma, et al.. (2020). Discovery of a Novel, Highly Potent, and Selective Thieno[3,2-d]pyrimidinone-Based Cdc7 Inhibitor with a Quinuclidine Moiety (TAK-931) as an Orally Active Investigational Antitumor Agent. Journal of Medicinal Chemistry. 63(3). 1084–1104. 16 indexed citations
4.
Kurasawa, Osamu, Yuya Oguro, T. Miyazaki, et al.. (2017). Identification of a new class of potent Cdc7 inhibitors designed by putative pharmacophore model: Synthesis and biological evaluation of 2,3-dihydrothieno[3,2-d]pyrimidin-4(1H)-ones. Bioorganic & Medicinal Chemistry. 25(7). 2133–2147. 14 indexed citations
5.
Kurasawa, Osamu, Misaki Homma, Yuya Oguro, et al.. (2017). 2-Aminomethylthieno[3,2-d]pyrimidin-4(3H)-ones bearing 3-methylpyrazole hinge binding moiety: Highly potent, selective, and time-dependent inhibitors of Cdc7 kinase. Bioorganic & Medicinal Chemistry. 25(14). 3658–3670. 10 indexed citations
6.
Oguro, Yuya, Douglas R. Cary, Naoki Miyamoto, et al.. (2013). Design, synthesis, and evaluation of novel VEGFR2 kinase inhibitors: Discovery of [1,2,4]triazolo[1,5-a]pyridine derivatives with slow dissociation kinetics. Bioorganic & Medicinal Chemistry. 21(15). 4714–4729. 38 indexed citations
7.
Miyamoto, Naoki, Nozomu Sakai, Takaharu Hirayama, et al.. (2013). Discovery of N-[5-({2-[(cyclopropylcarbonyl)amino]imidazo[1,2-b]pyridazin-6-yl}oxy)-2-methylphenyl]-1,3-dimethyl-1H-pyrazole-5-carboxamide (TAK-593), a highly potent VEGFR2 kinase inhibitor. Bioorganic & Medicinal Chemistry. 21(8). 2333–2345. 64 indexed citations
8.
9.
10.
Ohashi, Tomohiro, Yuya Oguro, Toshio Tanaka, et al.. (2012). Discovery of pyrrolo[3,2-c]quinoline-4-one derivatives as novel hedgehog signaling inhibitors. Bioorganic & Medicinal Chemistry. 20(18). 5496–5506. 55 indexed citations
11.
Miyamoto, Naoki, Yuya Oguro, Terufumi Takagi, et al.. (2012). Design, synthesis, and evaluation of imidazo[1,2-b]pyridazine derivatives having a benzamide unit as novel VEGFR2 kinase inhibitors. Bioorganic & Medicinal Chemistry. 20(24). 7051–7058. 19 indexed citations
12.
Ohashi, Tomohiro, Yuya Oguro, Toshio Tanaka, et al.. (2012). Discovery of the investigational drug TAK-441, a pyrrolo[3,2-c]pyridine derivative, as a highly potent and orally active hedgehog signaling inhibitor: Modification of the core skeleton for improved solubility. Bioorganic & Medicinal Chemistry. 20(18). 5507–5517. 60 indexed citations
13.
Tojo, Hideaki, Sachio Shibata, Yoshihiko Satoh, et al.. (2011). Abstract 2823: TAK-441, a novel investigational small molecule hedgehog pathway inhibitor for use in cancer therapy. Cancer Research. 71(8_Supplement). 2823–2823. 2 indexed citations
14.
Oguro, Yuya, Naoki Miyamoto, Terufumi Takagi, et al.. (2010). N-Phenyl-N′-[4-(5H-pyrrolo[3,2-d]pyrimidin-4-yloxy)phenyl]ureas as novel inhibitors of VEGFR and FGFR kinases. Bioorganic & Medicinal Chemistry. 18(20). 7150–7163. 26 indexed citations
15.
Oguro, Yuya, Naoki Miyamoto, Kengo Okada, et al.. (2010). Design, synthesis, and evaluation of 5-methyl-4-phenoxy-5H-pyrrolo[3,2-d]pyrimidine derivatives: Novel VEGFR2 kinase inhibitors binding to inactive kinase conformation. Bioorganic & Medicinal Chemistry. 18(20). 7260–7273. 95 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hanumantharayappa Bharathkumar Breakdown of academic impact, for papers by Han-Li Huang Breakdown of academic impact, for papers by Tatiana McHardy Breakdown of academic impact, for papers by Jonathan J. Hollick Breakdown of academic impact, for papers by Scott Wolfrom Breakdown of academic impact, for papers by Ching-Ping Chen Breakdown of academic impact, for papers by Jee Sun Yang Breakdown of academic impact, for papers by Taijin Wang Breakdown of academic impact, for papers by Mei‐Jung Lai Breakdown of academic impact, for papers by David R. Goode
Rankless by CCL
2026